Welcome to the Hope Bio Blog

FOR IMMEDIATE RELEASE By Jan Shultis Sugar Land, Texas, 3 February 2026 - A multicenter trial stretching across the southwestern United States is now recruiting patients to investigate whether allogeneic (donor-derived) Hope Biosciences Adipose-derived Mesenchymal Stem Cells (HB-adMSCs) can prevent progression of trauma-induced Acute Kidney Injury (AKI), an abrupt decline in renal function that occurs over hours to days in up to 50% of trauma and burn patients and has few eff

Hope Biosciences' Stem Cells Moves on to the Next Trial Stage for Traumatic Brain Injury with Support From The Department of Defense

As Houston-area biotechnology company Hope Biosciences marks its 7th year, the team thinks of big numbers—cells cultured, studies supported,